|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2022
de Leval, Laurence; Alizadeh, Ash A.; Bergsagel, P. Leif; Campo, Elias; Davies, Andrew; Dogan, Ahmet; Fitzgibbon, Jude; Horwitz, Steven M.; Melnick, Ari M.; Morice, William G.; Morin, Ryan D.; Nadel, Bertrand; Pileri, Stefano A.; Rosenquist, Richard; Rossi, Davide; Salaverria, Itziar; Steidl, Christian; Treon, Steven P.; Zelenetz, Andrew D.; Advani, Ranjana H.; Allen, Carl E.; Ansell, Stephen M.; Chan, Wing C.; Cook, James R.; Cook, Lucy B.; D'Amore, Francesco; Dirnhofer, Stefan; Dreyling, Martin; Dunleavy, Kieron; Feldman, Andrew L.; Fend, Falko; Gaulard, Philippe; Ghia, Paolo; Gribben, John G.; Hermine, Olivier; Hodson, Daniel J.; Hsi, Eric D.; Inghirami, Giorgio; Jaffe, Elaine S.; Karube, Kennosuke; Kataoka, Keisuke; Klapper, Wolfram; Kim, Won Seog; King, Rebecca L.; Ko, Young H.; LaCasce, Ann S.; Lenz, Georg; Martin-Subero, Jose I.; Piris, Miguel A.; Pittaluga, Stefania; Pasqualucci, Laura; Quintanilla-Martinez, Leticia; Rodig, Scott J.; Rosenwald, Andreas; Salles, Gilles A.; San-Miguel, Jesus; Savage, Kerry J.; Sehn, Laurie H.; Semenzato, Gianpietro; Staudt, Louis M.; Swerdlow, Steven H.; Tam, Constantine S.; Trotman, Judith; Vose, Julie M.; Weigert, Oliver; Wilson, Wyndham H.; Winter, Jane N.; Wu, Catherine J.; Zinzani, Pier L.; Zucca, Emanuele; Bagg, Adam und Scott, David W.
(2022):
Genomic profiling for clinical decision making in lymphoid neoplasms.
In: Blood, Bd. 140, Nr. 21: S. 2193-2227
2020
Dreyling, Martin; Tam, Constantine S.; Wang, Michael; Smith, Stephen D.; Ladetto, Marco; Huang, Huiqiang; Novotny, William; Co, Melannie; Romano, Alfredo; Holmgren, Eric; Huang, Jane und Le Gouill, Steven
(2020):
A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma.
In: Future Oncology, Bd. 17, Nr. 03: S. 255-262
2018
Agarwal, Rishu; Dawson, Mark A.; Dreyling, Martin und Tam, Constantine S.
(2018):
Understanding resistance mechanisms to BTK and BCL2 inhibitors in mantle cell lymphoma: implications for design of clinical trials.
In: Leukemia & Lymphoma, Bd. 59, Nr. 12: S. 2769-2781
Tam, Constantine S.; Anderson, Mary Ann; Pott, Christiane; Agarwal, Rishu; Handunnetti, Sasanka; Hicks, Rodney J.; Burbury, Kate; Turner, Gillian; Di Iulio, Juliana; Bressel, Mathias; Westerman, David; Lade, Stephen; Dreyling, Martin; Dawson, Sarah-Jane; Dawson, Mark A.; Seymour, John F. und Roberts, Andrew W.
(2018):
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma.
In: New England Journal of Medicine, Bd. 378, Nr. 13: S. 1211-1223